Live feed
Filing
SC 13D
SC 13D0000930413-18-000522·BIOCRYST PHARMACEUTICALS INC
Schedule 13D ownership disclosure
BIOCRYST PHARMACEUTICALS INC
Security class unavailable · CUSIP: 09058V103
Event date: 2018-02-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,478,275
- Percent of class
- 7.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000930413-18-000522
- Form type
- SC 13D
- Filer
- BIOCRYST PHARMACEUTICALS INC
- CIK
- CIK 882796
- Filed
- Feb 16, 2018
- Reporting period
- Feb 06, 2018
- Description
- Schedule 13D beneficial ownership